Search for: "LILLI JOHNSON" Results 81 - 100 of 242
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2012, 10:02 pm by Linda Moss
The three drugs in final tests, according to AP, are: Bapineuzumab, from Pfizer Inc. and Johnson & Johnson; Solanezumab, from Eli Lilly & Co.; and Gammagard, from Baxter International Inc. [read post]
4 Jun 2020, 7:00 am by Ronald Collins
We were shocked at the way Lillie was described by the author as having “maintained a bathing beauty figure. [read post]
30 May 2019, 6:50 pm by Scott McKeown
The second Wednesday panel will include the voice of small inventors (pro-reform) and include Phil Johnson (formerly Johnson & Johnson). [read post]
6 Feb 2012, 5:57 am by Pilar G. Kraman
Speakers: • Judge Paul Michel • Gary Griswold, former chairman, The Coalition for 21st Century Patent Reform • Bob Stoll, former commissioner for USPTO • Robert Armitage, senior VP and general counsel, Eli Lilly • Phil Johnson, chief intellectual property counsel, Johnson & Johnson • Sherry Knowles, principle, Knowles Intellectual Property Strategies • F. [read post]
27 Jun 2022, 9:01 pm by Paul Hodgson
Those were Eli Lilly, Gilead Sciences and Johnson & Johnson, all part of a U.S. pharmaceutical industry that spends more on lobbying than almost any other sector. [read post]
3 Aug 2011, 3:31 am by Marie Louise
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
8 Aug 2017, 12:10 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
21 Jul 2017, 3:14 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle. [read post]
27 May 2020, 3:03 am by Lynn Jokela
., Johnson & Johnson, Eli Lilly and Gilead Sciences), it seemed possible that the time had finally come for independent chairs in the pharmaceutical industry. [read post]
24 May 2020, 1:55 pm by Renee Knake
This post is part of a series about my new book Shortlisted: Women in the Shadows of the Supreme Court, co-authored with Hannah Brenner Johnson. [read post]
31 May 2019, 9:47 am by Rebecca Tushnet
Long post, lots of stuff to cover in this opinion.MillerCoors, LLC v. [read post]
22 Sep 2011, 3:39 am by Bob Kraft
” The story reports on payments by Eli Lilly and Co., down 46 percent since 2009; GlaxoSmithKline down 29 percent. [read post]
6 May 2011, 8:37 am by Kara OBrien
Johnson & Johnson, previously included in the group of companies under investigation, resolved an FCPA enforcement action last month and Koehler thinks their enforcement action provides a glimpse into potential future FCPA enforcement actions involving the pharmaceutical/medical device industry. [read post]
24 Oct 2010, 10:10 pm
In addition to Lilly and Cephalon, the companies include AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Merck & Co., and Pfizer. [read post]